Life Sciences PhD in Genome Stability (2023)

A PhD studentship (3.5 years) is available from September 2023 under the supervision of Prof Helfrid Hochegger (Genome Damage and Stability Centre) and Prof. John Spencer (Sussex Drug Discovery Centre) School of Life Sciences.

What you get

This School-funded position covers Home tuition fees and a stipend at standard UKRI rates for 3.5 years. Applicants with overseas fee status will need to fund the difference between Home and International tuition fees (approx. £18k per year).

Type of award

Postgraduate Research

Funding type

School funded

PhD project

Establishing induced degradation approaches to support PROTAC based drug discovery

The major aim of this project is to assist in the validation of induced protein degradation as a viable strategy to develop novel anti-cancer therapies. Induced degradation of specific targets using small molecules called PROTACs has recently gained considerable attention in the drug discovery field. However, developing these molecules poses considerable challenges to medicinal chemists. Moreover, it is often unclear if induced degradation is advantageous compared to conventional inhibition mechanisms.  We aim to address these challenges by establishing a genetic approach to induced degradation. This involves the introduction of degron-tags into endogenous genomic loci for proteins of interest using CRIPSR mediated gene targeting. A variety of different tags are available for this purpose and also several different CRISPR techniques to ensure optimal targeting efficacy. In this project we aim to optimise a workflow for this technique that can be applied in an efficient target validation workflow for drug discovery on a variety of targets and cellular model systems. The student working on this project will be integrated in a vibrant interdisciplinary research environment at the crossing of chemical genetics, cancer cell biology and drug discovery and will be co-supervised by Prof. Hochegger an expert in cell biology and Prof. John Spencer the Director of the Sussex Drug Discovery centre. We are looking for ambitious and enthusiastic applicants with a background in genetics and cell biology and an interest in cancer biology and drug discovery.

Eligibility

Ideal candidates will have a strong background in cell biology and cancer biology.

Eligible applicants will hold a 2:1 BSc in a relevant subject.

Candidates for whom English is not their first language will require an IELTS score of 6.5 overall, with not less than 6.0 in any section.

Deadline

28 February 2023 23:45

How to apply

How to apply:

Please submit a formal application using the online admissions portal attaching a CV, degree transcripts and certificates, personal statement and two academic references.

On the application system select Programme of Study – PhD Genome Stability. Please state the project title under funding and the supervisor’s name where required.

Contact us

For enquiries about the application process, contact Emma Chorley: lifesci-rec@sussex.ac.uk

For enquiries about the project, contact supervisor: hh65@sussex.ac.uk

For further information, please see: www.sussex.ac.uk/lifesci/hocheggerlab , www.helfrid.github.io

Availability

At level(s):
PG (research)

Application deadline:
28 February 2023 23:45 (GMT)
the deadline has now expired

Countries

The award is available to people from these specific countries: